Lingyun Ji

Dr. Lingyun Ji is an Associate Professor of Clinical Biostatistics at the University of Southern California, specializing in clinical trial design and oncology research. She leads statistical efforts for the Children’s Oncology Group (COG), focusing on pediatric and adult leukemia studies. Her research emphasizes Bayesian adaptive designs, survival analysis, and translational cancer methodologies. She collaborates extensively on trials evaluating therapies like blinatumomab and inotuzumab ozogamicin in acute lymphoblastic leukemia (ALL). Dr. Ji’s work addresses disparities in clinical trial enrollment and outcomes for minority and adolescent populations. Her contributions span over 100 peer-reviewed articles, with recent focus on pediatric oncology, biostatistical innovation, and precision medicine.